secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tourmaline Bio, Inc. (—)
CIK:        0001827506
Form:       8-K
Filed at:   2024-10-10T23:59:59+00:00
Accession:  0001827506-24-000086
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Tourmaline Bio CMO Dr. Yung Chyung resigns effective Oct 31, 2024
-----------------------------------------------------------------

- Dr. Yung Chyung resigns as Chief Medical Officer effective October 31, 2024.
- Resignation is voluntary to pursue other opportunity; no disagreement with company.
- He will stay through Oct 31 to assist transition; duties assumed by senior management.
- Company has initiated a search for his successor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1827506/000182750624000086/0001827506-24-000086-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1827506/000182750624000086/trml-20241004.htm
  HTML page:      https://secwatch.observer/filing/0001827506-24-000086

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer